News

Women With Familial Hypercholesterolemia Have a Significantly Lower Cardiovascular Risk Than Men

On the occasion of Familial Hypercholesterolemia (FH) Awareness Day, the Sant Pau Research Institute (IR Sant Pau) highlights its commitment to biomedical research aimed at improving the diagnosis and...

Personalized Solutions for Cardiac Device Complications With the Support of CaixaImpulse 2025

The Sant Pau Research Institute (IR Sant Pau) has been selected in the CaixaImpulse 2025 call by the “la Caixa” Foundation to promote an innovative project in the field of cardiology. This project...

Experts Outline the Healthcare, Policy, and Social Changes Needed to Fully Harness Advances in Alzheimer’s Treatment

The approval of new antibody-based drugs for Alzheimer’s disease—lecanemab and donanemab—and of blood-based diagnostic tests marks the beginning of a new era in the diagnosis and treatment of th...

Cancer Research at Sant Pau Achieves Breakthroughs in Survival and Quality of Life

Cancer continues to be one of the leading causes of death worldwide and in Spain. According to the report Cancer Figures in Spain 2025 by the Spanish Society of Medical Oncology (SEOM), nearly 300,000...

International Review Identifies the Most Reliable Tests to Assess Attention, Working Memory, and Executive Functions in Parkinson’s Disease

An international group of experts, including Dr. Saül Martínez-Horta, researcher at the Sant Pau Research Institute (IR Sant Pau) and neuropsychologist at the Movement Disorders Unit of Hospital San...